Product Name | NebuSelect™ Recombinant Biotinylated Human CD20/MS4A1, Avi-His-tag |
---|---|
Catalog Number | NBL-240477 |
Alias/Synonyms | CD20/MS4A1; MS4A1;CD20;MS4A-1;B-lymphocyte surface antigen B1;Bp35;Leukocyte surface antigen Leu-16;Membrane-spanning 4-domains subfamily A member 11 |
Appearance | see COA |
Molecule Weight | Ile141-Ser188 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | P11836-1 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240477-100ug | 100ug | Inquire | Inquire | |
NBL-240477-1mg | 1mg | Inquire | Inquire | |
NBL-240477-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human CD20/MS4A1, Avi-His-tag
Catalog#:
NBL-240477
Description:
NebuSelect™ Recombinant Biotinylated Human CD20/MS4A1, Avi-His-tag(Cat#NBL-240477) is expressed in E.coli with His tag and Avi tag at the C-Terminus.It contains Ile141-Ser188.
Species:
Human
Expression System:
E.coli
Molecular Weight:
The protein has a predicted MW of 16.8 kDa same as Bis-Tris PAGE result.
Target Name:
CD20/MS4A1; MS4A1;CD20;MS4A-1;B-lymphocyte surface antigen B1;Bp35;Leukocyte surface antigen Leu-16;Membrane-spanning 4-domains subfamily A member 11
Target Information:
B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases.
Amino Acid Sequence:
Ile141-Ser188
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.